12147242 |
Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH
Tokunaga, A,
Sakamoto, H,
Matsukura, N,
Sasaki, H,
Tajiri, T,
Ishizuka, T,
Tanabe, C,
Yoshida, T,
Terada, M,
Aoyagi, K,
Maekawa, M
|
Biochem Biophys Res Commun |
2002 |
14614009 |
Gene amplifications associated with the development of hormone-resistant prostate cancer
Witton, CJ,
Edwards, J,
Bartlett, JM,
Krishna, NS
|
Clin Cancer Res |
2003 |
14729606 |
Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines
Kleer, CG,
Albertson, D,
Washburn, JG,
Ethier, SP,
Yang, ZQ,
Ray, ME,
Macoska, JA
|
Cancer Res |
2004 |
21367659 |
Targeting mutant fibroblast growth factor receptors in cancer
Pollock, PM,
Greulich, H
|
Trends Mol Med |
2011 |
17699850 |
High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications
Sridhar, A,
Campbell, IG,
Choong, DY,
Qiu, W,
Jacobs, S,
Gorringe, KL,
Thompson, ER
|
Clin Cancer Res |
2007 |
11389083 |
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer
Jäger, P,
Hardmeier, T,
Ackermann, D,
Wagner, U,
Flury, R,
Maurer, R,
Sauter, G,
Knönagel, H,
Alund, G,
Anabitarte, M,
Gasser, T,
Hering, F,
Moch, H,
Schmid, U,
Wilber, K,
Mihatsch, MJ,
Schraml, P,
Schönenberger, A,
Richter, J,
Simon, R,
Rist, M,
Fehr, JL,
Bruderer, J,
Fijan, A
|
Cancer Res |
2001 |
18068632 |
Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition
Spencer, DM,
Peterson, LE,
Wang, F,
Acevedo, VD,
Li, R,
Freeman, KW,
Ittmann, M,
Ayala, GE,
Gangula, RD,
Zhang, Y
|
Cancer Cell |
2007 |
21160078 |
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer
Sietsma, H,
Smit, E,
Solomon, B,
Sollberg, S,
Soltermann, A,
Sos, ML,
Stoelben, E,
Thomas, RK,
Sänger, J,
Timens, W,
Thunnissen, E,
Wagener, P,
Cappuzzo, F,
Buettner, R,
Brustugun, OT,
Brambilla, E,
Brambilla, C,
Baumann, M,
Beroukhim, R,
Baessmann, I,
Balke-Want, H,
Ansén, S,
Altmüller, J,
Zander, T,
Wright, G,
Leenders, F,
Koker, M,
Heynck, S,
Klebl, B,
Heukamp, LC,
Heuckmann, JM,
Hallek, M,
Heideman, D,
Groen, H,
Fischer, F,
Gabler, F,
Ernestus, K,
Engel-Riedel, W,
Damiani, S,
Conron, M,
Dabow, I,
Clement, J,
Seidel, D,
Schöttle, J,
Russell, P,
Rauh, D,
Petersen, I,
Querings, S,
Perner, S,
Nürnberg, P,
Peifer, M,
Moch, H,
Menon, R,
Ludwig, C,
Maier, S,
Ligorio, C,
Lorimier, P,
Wolf, J,
Pao, W,
Weiss, J,
Wainer, Z,
Ullrich, RT
|
Sci Transl Med |
2010 |
20094046 |
Fibroblast growth factor signalling: from development to cancer
Grose, RP,
Turner, N
|
Nat Rev Cancer |
2010 |
21666749 |
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Mermel, C,
Hammerman, PS,
Greulich, H,
Gray, NS,
Ramos, AH,
Cho, J,
Chande, A,
Dutt, A,
Tanaka, KE,
Stransky, N,
Meyerson, M,
Sharifnia, T
|
PLoS One |
2011 |
16807070 |
Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC)
Hofele, C,
Flechtenmacher, C,
Schwaenen, C,
Mühling, J,
Lichter, P,
Sticht, C,
Radlwimmer, B,
Freier, K,
Joos, S
|
Oral Oncol |
2007 |
19801978 |
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Jr, UR,
Stairs, DB,
Kim, SY,
Minna, JD,
Rao, S,
Komisarof, J,
Tamayo, P,
Lafargue, CJ,
Gat-Viks, I,
Regev, A,
Bass, AJ,
Beer, DG,
Gazdar, AF,
Tsao, MS,
Marie, SK,
Giordano, TJ,
Lin, L,
Ma, C,
Rozenblatt-Rosen, O,
Ramos, AH,
Brose, MS,
Verhaak, RG,
Rustgi, AK,
Wong, KK,
Rubin, MA,
Hahn, WC,
Wagner, P,
Meyerson, M,
Cecconello, I,
Woo, MS,
Chirieac, LR,
Wardwell, L,
Mermel, CH,
Scheble, V,
Watanabe, H,
Dahl, O,
Weir, BA,
Wilbertz, T,
Beroukhim, R,
Perner, S,
Nakagawa, H,
Dziunycz, P,
Shivdasani, RA,
Getz, G,
Dutt, A,
Yu, S,
O'Kelly, M,
Zhu, CQ
|
Nat Genet |
2009 |
18757432 |
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer
Delattre, O,
Pierron, G,
Reyal, F,
Stransky, N,
Bernard-Pierrot, I,
Radvanyi, F,
Vallot, C,
Gruel, N,
Raynal, V,
Vincent-Salomon, A
|
Cancer Res |
2008 |
19235922 |
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development
Missiaglia, E,
Pritchard-Jones, K,
Schaaf, G,
Selfe, J,
Summersgill, B,
Versteeg, R,
Williamson, D,
Hamdi, M,
Fang, C,
Kool, M,
Koster, J,
Messahel, B,
Shipley, J
|
Genes Chromosomes Cancer |
2009 |
20179196 |
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
Marchio, C,
Ashworth, A,
Reis-Filho, JS,
Lambros, M,
Iorns, E,
Gillett, C,
Geyer, F,
Natrajan, R,
Sharpe, R,
Lopez-Garcia, MA,
Turner, N,
Tutt, A,
Grigoriadis, A,
Mackay, A,
Pearson, A
|
Cancer Res |
2010 |
17121884 |
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Sarrio, D,
Hardisson, D,
Savage, K,
Weber, B,
Schmitt, FC,
Ashworth, A,
Lambros, MB,
Reis-Filho, JS,
Dexter, T,
Iravani, M,
Turner, NC,
Jones, C,
Fenwick, K,
Grigoriadis, A,
Lakhani, SR,
Palacios, J,
Simpson, PT,
Mackay, A
|
Clin Cancer Res |
2006 |
18849352 |
Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells
Marek, L,
Heasley, LE,
Helfrich, BA,
Coldren, CD,
Fritzsche, A,
Ware, KE,
Hercule, P,
McDermott, LA,
Helton, WR,
Merrick, DT,
Nemenoff, RA,
Bunn PA, Jr,
Smith, JE
|
Mol Pharmacol |
2009 |